EyeGate Pharmaceuticals EYEG Stock
$34.55
-0.403869%
Add to favorites
COUNTRY
Exchange
Market Cap
$0.00
LOW - HIGH [24H]
$34.54
-
$34.55
VOLUME [24H]
$516.00
P/E Ratio
0
Earnings per share
$0.00
EyeGate Pharmaceuticals Price Chart
EyeGate Pharmaceuticals EYEG Financial and Trading Overview
| EyeGate Pharmaceuticals stock price | 34.55 USD |
| Previous Close | 34.69 USD |
| Open | 34.54 USD |
| Bid | 24.86 USD x 200 |
| Ask | 44.24 USD x 200 |
| Day's Range | 34.54 - 34.54 USD |
| 52 Week Range | 34.54 - 36.63 USD |
| Volume | 511 USD |
| Avg. Volume | 219 USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EYEG Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
EyeGate Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 36.63 USD |
| 52 Week Low | 34.54 USD |
| 50-Day Moving Average | 35.14 USD |
| 200-Day Moving Average | 35.63 USD |
EYEG Share Statistics
| Avg. Volume (3 month) | 219 USD |
| Avg. Daily Volume (10-Days) | 210 USD |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of EyeGate Pharmaceuticals
| Country | United States |
| State | N/A |
| City | N/A |
| Address | N/A |
| ZIP | N/A |
| Phone | N/A |
| Website | N/A |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest.
Q&A For EyeGate Pharmaceuticals Stock
What is a current EYEG stock price?
EyeGate Pharmaceuticals EYEG stock price today per share is 34.55 USD.
How to purchase EyeGate Pharmaceuticals stock?
You can buy EYEG shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EyeGate Pharmaceuticals?
The stock symbol or ticker of EyeGate Pharmaceuticals is EYEG.
How many shares does EyeGate Pharmaceuticals have in circulation?
The max supply of EyeGate Pharmaceuticals shares is 0.
What is EyeGate Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
EyeGate Pharmaceuticals PE Ratio is now.
What was EyeGate Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
EyeGate Pharmaceuticals EPS is 0 USD over the trailing 12 months.
EyeGate Pharmaceuticals EYEG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Capital Market Composite
RCMP
US
|
137.82 USD — |
-0.9
|
— — | 136.96 USD — | 139.4 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31010.88 USD — |
-2.15
|
— — | 30785.22 USD — | 31283.01 USD — | — - | — — |
- {{ link.label }} {{link}}